Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03345485
Title Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mundipharma-EDO GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | ESP | CAN

Facility Status City State Zip Country Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
Stanford University Medical Center Palo Alto California 94304 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
New York University New York New York 10016 United States Details
Mary Crowley Cancer Research Dallas Texas 75251 United States Details
Juravinski Cancer Centre Hamilton Ontario, ON L8V 1C3 Canada Details
McGill University Montréal Quebec H4A 3J1 Canada Details
BC Cancer-Vancouver Vancouver Vancouver, BC V5Z 1M9 Canada Details
Fondazione IRCCS Istituto Nazionale dei Tumori Milan 20133 Italy Details
Istituto Europeo di Oncologia Milan MI 20141 Italy Details
Erasmus MC Kanker Instituut Rotterdam 3015 Netherlands Details
Hospital Universitario La Paz Madrid Fuencarral-El Pardo 28046 Spain Details
Hospital Universitari Vall d'Hebron Barcelona Horta-Guinardó 08035 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field